Tuesday, January 27, 2015 6:49:10 PM
http://www.bluebirdbio.com/about-management.php
Nick Leschly has served as our president and chief executive officer since September 2010. Previously, he served as our interim chief executive officer from March 2010 to September 2010. Formerly a partner of Third Rock Ventures, L.P. since its founding in 2007, Mr. Leschly played an integral role in the overall formation, development and business strategy of several of Third Rock's portfolio companies, including Agios Pharmaceuticals, Inc. and Edimer Pharmaceuticals, Inc. Prior to joining Third Rock, he worked at Millennium Pharmaceuticals, Inc., leading several early-stage drug development programs and served as the product and alliance leader for VELCADE. Mr. Leschly also founded and served as chief executive officer of MedXtend Corporation. He received his B.S. in molecular biology from Princeton University and his MBA. from Wharton Business School. He currently serves as a member of the Biotechnology Industry Organization board.
Recent BLUE News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:01:50 AM
- bluebird bio Reports First Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance • Business Wire • 05/09/2024 11:00:00 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio, Inc. Lawsuit - BLUE • PR Newswire (US) • 05/07/2024 09:45:00 AM
- bluebird bio Announces First Quarter 2024 Results Call Date and Upcoming Investor Events • Business Wire • 05/06/2024 11:05:00 AM
- bluebird bio Announces Completion of First Cell Collection for LYFGENIA™ Gene Therapy • Business Wire • 05/06/2024 11:00:00 AM
- Class Action Filed Against bluebird bio, Inc. (BLUE) - May 28, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 05/03/2024 09:45:00 AM
- bluebird bio Announces Receipt of Expected Notice from Nasdaq • Business Wire • 04/26/2024 08:05:00 PM
- The Gross Law Firm Notifies bluebird bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline • PR Newswire (US) • 04/26/2024 09:45:00 AM
- bluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - BLUE • PR Newswire (US) • 04/19/2024 09:45:00 AM
- Class Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors - Contact The Gross Law Firm • PR Newswire (US) • 04/16/2024 09:45:00 AM
- Shareholders that lost money on bluebird bio, Inc.(BLUE) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 04/12/2024 09:45:00 AM
- bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/11/2024 12:00:00 PM
- bluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before May 28, 2024 to Discuss Your Rights - BLUE • PR Newswire (US) • 04/09/2024 09:45:00 AM
- Shareholders that lost money on bluebird bio, Inc.(BLUE) should contact The Gross Law Firm about pending Class Action - BLUE • PR Newswire (US) • 04/05/2024 09:45:00 AM
- bluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 Guidance • Business Wire • 03/26/2024 11:01:00 AM
- bluebird bio to Host Fourth Quarter and 2023 Annual Results Conference Call • Business Wire • 03/25/2024 08:05:00 PM
- bluebird bio Secures up to $175 Million Debt Financing with Hercules Capital • Business Wire • 03/18/2024 12:00:00 PM
- bluebird bio Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene Therapy • Business Wire • 03/11/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:40:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:40:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:40:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:39:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:39:41 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 06:54:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 09:07:54 PM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM